Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity

Virology

Volumn 315, Issue 1, 2003, Pages 209-216

  Nack, Ursula ^a   Schnierle, Barbara S ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Envelope incorporation; HIV; MLV; Pseudotyping; Truncated envelope

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; VIRUS RNA;

ARTICLE; CELL STRAIN; CHIMERA; EMBRYO; ENVELOPE GENE; GENE REPLICATION; GENE SEQUENCE; GENETIC CODE; HEPATITIS VIRUS; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; TRANSCRIPTION REGULATION; VIRAL GENETICS; VIRUS INFECTION; VIRUS PARTICLE; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MARMOTA MONAX; MURINAE; MURINE LEUKEMIA VIRUS; WOODCHUCK HEPATITIS B VIRUS;

EID: 0242331311     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00519-1     Document Type: Article

References (33)

1. Bieniasz P.D., Grdina T.A., Bogerd H.P., Cullen B.R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:1998;7056-7065.
2. Blot G., Janvier K., Le Panse S., Benarous R., Berlioz-Torrent C. Targeting of the human immunodeficiency virus type 1 envelope to the trans-golgi network through binding to TIP47 is required for Env incorporation into virions and infectivity. J. Virol. 77:2003;6931-6945.
3. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:1997;296-300.
4. Erlwein O., Buchholz C.J., Schnierle B.S. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus. J. Gen. Virol. 84:2003;369-373.
5. Erlwein O., Wels W., Schnierle B.S. Chimeric ecotropic MLV envelope proteins that carry EGF receptor-specific ligands and the Pseudomonas exotoxin A translocation domain to target gene transfer to human cancer cells. Virology. 302:2002;333-341.
6. Freed E.O., Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
7. Green S., Issemann I., Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:1988;369.
8. Hammarskjold M.L., Li H., Rekosh D., Prasad S. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. J. Virol. 68:1994;951-958.
9. Harbers K., Schnieke A., Stuhlmann H., Jahner D., Jaenisch R. DNA methylation and gene expression endogenous retroviral genome becomes infectious after molecular cloning . Proc. Natl. Acad. Sci. USA. 78:1981;7609-7613.
10. Hohne M., Thaler S., Dudda J.C., Groner B., Schnierle B.S. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Virology. 261:1999;70-78.
11. Huang Y., Wimler K.M., Carmichael G.G. Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing. EMBO J. 18:1999;1642-1652.
12. Indraccolo S., Minuzzo S., Feroli F., Mammano F., Calderazzo F., Chieco-Bianchi L., Amadori A. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther. 5:1998;209-217.
13. Iwatani Y., Ueno T., Nishimura A., Zhang X., Hattori T., Ishimoto A., Ito M., Sakai H. Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein. Virus Res. 74:2001;75-87.
14. Killeen N., Sawada S., Littman D.R. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12:1993;1547-1553.
15. Lindemann D., Bock M., Schweizer M., Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:1997;4815-4820.
16. Mammano F., Salvatori F., Indraccolo S., De Rossi A., Chieco-Bianchi L., Gottlinger H.G. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 71:1997;3341-3345.
17. Mariani R., Rutter G., Harris M.E., Hope T.J., Krausslich H.G., Landau N.R. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74:2000;3859-3870.
18. Nasioulas G., Zolotukhin A.S., Tabernero C., Solomin L., Cunningham C.P., Pavlakis G.N., Felber B.K. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:1994;2986-2993.
19. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA. 93:1996;11400-11406.
20. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 52:1998;491-532.
21. Popa I., Harris M.E., Donello J.E., Hope T.J. CRM1-dependent function of a cis-acting RNA export element. Mol. Cell. Biol. 22:2002;2057-2067.
22. Reed M., Mariani R., Sheppard L., Pekrun K., Landau N.R., Soong N.W. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J. Virol. 76:2002;436-443.
23. Rousso I., Mixon M.B., Chen B.K., Kim P.S. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. USA. 97:2000;13523-13525.
24. Schnierle B.S., Moritz D., Jeschke M., Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3:1996;334-342.
25. Schnierle B.S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA. 94:1997;8640-8645.
26. Shinnick T.M., Lerner R.A., Sutcliffe G.J. Nucleotide sequence of Moloney murine leukaemia virus. Nature. 293:1981;543-548.
27. Steffens C.M., Hope T.J. Recent advances in the understanding of HIV accessory protein function. AIDS. 15:(Suppl. 5):2001;S21-S26.
28. Stitz J., Steidl S., Merget-Millitzer H., Konig R., Muller P., Nocken F., Engelstadter M., Bobkova M., Schmitt I., Kurth R., Buchholz C.J., Cichutek K. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Virology. 267:2000;229-236.
29. Thaler S., Schnierle B.S. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes. Mol. Ther. 4:2001;273-279.
30. Vogt B., Roscher S., Abel B., Hildinger M., Lamarre A., Baum C., von Laer D. Lack of superinfection interference in retroviral vector producer cells. Hum. Gene Ther. 12:2001;359-365.
31. Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 189:1992;167-177.
32. Yu X., Yuan X., McLane M.F., Lee T.H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:1993;213-221.
33. Zufferey R., Donello J.E., Trono D., Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:1999;2886-2892.